CareLit · DOI-Nachweis · Zentralblatt für Gynäkologie
Prognostic Significance of Isolated Tumor Cells (ITC) in the Bone Marrow (BM) of Breast Cancer Patients During Recurrence-free Follow-up and Therapeutic Intervention with Zoledronate
DOI 10.1055/s-2005-921013
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Rack, W Janni, C Schindlbeck, B Strobl, T Blankenstein, M Heinrigs, D Rjosk, H Sommer, K Friese
ZeitschriftZentralblatt für Gynäkologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: If the persistence of ITC after adjuvant therapy is associated with risk for recurrence, it would be an indication to consider secondary adjuvant treatment. Cell-cycle independent agents might be effective in the elimination of dormant cells. Methods: We analyzed BM aspirates from 228 pts during recurrence-free follow-up at a median interval of 21.3mon after primary diagnosis. ITC were detected by monoclonal a…
Zitieren
Zitierempfehlung
B Rack, W Janni, C Schindlbeck, B Strobl, T Blankenstein, M Heinrigs, D Rjosk, H Sommer, K Friese (2005) Prognostic Significance of Isolated Tumor Cells (ITC) in the Bone Marrow (BM) of Breast Cancer Patients During Recurrence-free Follow-up and Therapeutic Intervention with Zoledronate. Zentralblatt für Gynäkologie (10). https://doi.org/10.1055/s-2005-921013
Mit CareLit weiterarbeiten